PHARMA DANCKAERT: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA DANCKAERT
Largest movements
- Receivables within one year +€10,457
up €10,457 (+17.4%), from €60,050 to €70,507
of which Other amounts receivable: +€12,132
- Stocks and contracts +€6,369
up €6,369 (+13.6%), from €46,697 to €53,066
- Other debts +€33,900
up €33,900 (+115.6%), from €29,332 to €63,232
- Trade debts -€11,844
down €11,844 (-37.2%), from €31,806 to €19,962
- Profit (loss) carried forward -€8,462
down €8,462 (-60.0%), from -€14,108 to -€22,570
- Short-term financial debts +€4,059
up €4,059 (+47.8%), from €8,483 to €12,541
- Gross operating margin +€15,859
up €15,859 (+29.5%), from €53,746 to €69,605
- Staff costs +€6,097
up €6,097 (+9.5%), from €64,485 to €70,583
- Depreciation -€1,728
down €1,728 (-71.5%), from €2,418 to €690
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €114,729 | €132,287 | +€17,558 | +15.3% |
| Fixed assets | 21/28 | €3,791 | €3,567 | -€224 | -5.9% |
| Tangible fixed assets | 22/27 | €3,791 | €3,567 | -€224 | -5.9% |
| Plant, machinery and equipment | 23 | €3,791 | €3,567 | -€224 | -5.9% |
| Current assets | 29/58 | €110,938 | €128,719 | +€17,782 | +16.0% |
| Stocks and contracts in progress | 3 | €46,697 | €53,066 | +€6,369 | +13.6% |
| Stocks | 30/36 | €46,697 | €53,066 | +€6,369 | +13.6% |
| Amounts receivable within one year | 40/41 | €60,050 | €70,507 | +€10,457 | +17.4% |
| Trade receivables | 40 | €34,514 | €32,840 | -€1,674 | -4.9% |
| Other amounts receivable | 41 | €25,536 | €37,668 | +€12,132 | +47.5% |
| Deferred charges and accrued income | 490/1 | €4,191 | €5,145 | +€955 | +22.8% |
| Total equity and liabilities | 10/49 | €114,729 | €132,287 | +€17,558 | +15.3% |
| Equity | 10/15 | €43,328 | €34,866 | -€8,462 | -19.5% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €7,436 | €7,436 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,235 | €6,235 | = | 0.0% |
| Reserves not available under the articles | 1311 | €6,235 | €6,235 | = | 0.0% |
| Tax-exempt reserves | 132 | €1,202 | €1,202 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€14,108 | -€22,570 | -€8,462 | -60.0% |
| Amounts payable | 17/49 | €71,401 | €97,420 | +€26,020 | +36.4% |
| Amounts payable within one year | 42/48 | €71,401 | €97,420 | +€26,020 | +36.4% |
| Financial debts | 43 | €8,483 | €12,541 | +€4,059 | +47.8% |
| Credit institutions | 430/8 | €8,483 | €12,541 | +€4,059 | +47.8% |
| Trade debts | 44 | €31,806 | €19,962 | -€11,844 | -37.2% |
| Suppliers | 440/4 | €31,806 | €19,962 | -€11,844 | -37.2% |
| Taxes, remuneration and social security | 45 | €1,780 | €1,685 | -€95 | -5.3% |
| Taxes | 450/3 | €1,780 | €1,685 | -€95 | -5.3% |
| Other amounts payable | 47/48 | €29,332 | €63,232 | +€33,900 | +115.6% |
| Remuneration, social security and pensions | 62 | €64,485 | €70,583 | +€6,097 | +9.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,418 | €690 | -€1,728 | -71.5% |
| Other operating charges | 640/8 | €382 | €408 | +€26 | +6.8% |
| Gross operating margin | 9900 | €53,746 | €69,605 | +€15,859 | +29.5% |
| Operating profit (loss) | 9901 | -€13,539 | -€2,075 | +€11,464 | +84.7% |
| Financial income | 75/76B | €24 | €5 | -€19 | -79.0% |
| Recurring financial income | 75 | €24 | €5 | -€19 | -79.0% |
| Financial charges | 65/66B | €6,552 | €6,392 | -€160 | -2.4% |
| Recurring financial charges | 65 | €6,552 | €6,392 | -€160 | -2.4% |
| Profit (loss) for the period before taxes | 9903 | -€20,067 | -€8,462 | +€11,606 | +57.8% |
| Profit (loss) for the period | 9904 | -€20,067 | -€8,462 | +€11,606 | +57.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€20,067 | -€8,462 | +€11,606 | +57.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.